πŸ‡ΊπŸ‡Έ FDA
Patent

US 9896664

Oncolytic rhabdovirus

granted A61KA61K35/766A61K35/768

Quick answer

US patent 9896664 (Oncolytic rhabdovirus) held by TURNSTONE LIMITED PARTNERSHIP expires Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNSTONE LIMITED PARTNERSHIP
Grant date
Tue Feb 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K35/766, A61K35/768, A61K45/06, A61P